• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Rosch slams ObamaCare’s ACOs

Rosch slams ObamaCare’s ACOs

November 18, 2011 By Emily Greenhalgh

rosch

U.S. Federal Trade Commissioner J.Thomas Rosch slammed the accountable care organizations instituted by ObamaCare at an antitrust conference yesterday, saying that Medicare cost savings would actually lead to higher overall costs and lower quality patient care.

The ACO initiative aims to shift the business of health care delivery from a fee-for-service model to one that pays hospitals and care providers based on quality of care, coordination of care and cost-effectiveness. It’s slated to kick off on a voluntary basis next year.

In his speech, titled "Accountable Care Organizations: What Exactly are We Getting," Rosch said that while the idea of using financial incentives to reduce costs and improve quality of care is a good one, he’s skeptical that ACOs will lead to any net savings.

Sign up to get our free newsletters delivered straight to your inbox

The Congressional budget office projected that ACO formation would save Medicare $5.3 billion over the next ten years.

The total estimated Medicare spending during that period is projected to be over $7 trillion, making ACO savings less than one tenth of one percent of total Medicare spending over the next decade.

"In other words, even under the most optimistic scenario, the savings to Medicare from the ACO program are no more than a rounding error," said Rosch.

Still, Rosch called the projected savings "likely overstated."

The commissioner compared the ACO program to the existing Physician Group Practice Demonstration that created incentives for doctors to coordinate care delivered to Medicare patients and rewards them for improving cost and quality of life.

The results, according to Rosch "were nothing to crow about." Figures from the Centers for Medicare & Medicaid Services showed no notable savings from the majority of participating practice groups.

Rosch warned the antitrust conference attendees that any reduction in costs from a shared savings program would likely be borne by commercial payers and result in lower quality patient care.

"Whatever one thinks about the health care reform legislation from 2010, it’s hard not to be skeptical about the prospects of the Medicare Shared Savings Program," said Rosch, insisting that the net result of APOs and shared savings programs would be higher costs and lower quality health care – the exact opposite of the intended goal.

The ACO program has been praised by industry, with some words of warning.

In an opinion piece published on the Health Affairs blog earlier this year, industry lobby AdvaMed president & CEO Stephen Ubl wrote that the ACO program "is the right treatment to fix the ills of our nation’s health system," but cautioned that it runs a "real danger of stinting on care" for Medicare patients.

Ubl added that the program needs  "protections to ensure appropriate care for individual patients," namely an independent oversight board to prevent "arbitrary ‘stinting’" from rationing care for individual patients.

The final ACO rules include improvements suggested by comments collected during the year,  Medicare chief Donald Berwick said in a press release.

After months of review, the federal government finalized the rules for accountable care organizations in October. The ACOs are set to begin formation in 2012.

Filed Under: Healthcare Reform, News Well Tagged With: Federal Trade Commission (FTC)

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy